New York's Medical Schools Urge Governor Hochul to Boost Funding for Biomedical Research Amid Uncertainty Over Federal Dollars
A coalition of New York medical schools and prominent research institutions is pushing Governor Kathy Hochul to commit billions of state dollars to a new biomedical research fund, citing the need to sustain existing research and jobs threatened by federal funding cuts under the Trump administration.
The proposed Empire Biomedical Research Institute would not only support ongoing research but also fuel New York's life sciences sector in the long term. According to supporters, including Jonathan Teyan, president and CEO of the Associated Medical Schools of New York, the new fund is essential for economic development and healthcare in New York state.
Federal funding for biomedical research has had a significant impact on the state, with over 30,000 jobs generated and $8 billion in economic activity last year. However, more than 1,000 research grants in New York have been impacted by federal funding cuts or freezes, leaving hundreds still affected.
The Associated Medical Schools of New York proposes starting the new state fund at $500 million and expanding it to $6 billion over the next decade. However, the proposal faces stiff competition for state funding going into the fiscal year 2027 budget session, with other high-priority initiatives on the table.
Ana Champeny, vice president for research at the Citizens Budget Commission, notes that lawmakers will need to determine priorities and allocate funds accordingly. "The legislators and the governor will need to figure out what are the priorities," she said.
Institutions such as Mount Sinai Health System, Columbia University, and the CUNY School of Medicine have made their case for prioritizing biomedical research in a letter to Governor Hochul, warning that without such a fund, they risk losing ground to other states and countries expanding their commitments to biomedical research.
New York state is already investing heavily in life sciences and innovation, including a $150 million investment in a cell and gene therapy innovation hub on Long Island. However, supporters argue that the state must also commit to supporting research at academic institutions to fuel the pipeline to commercial sector success.
The proposal comes as federal science funding remains in flux, with researchers saying research is still hobbled despite some reversals of cutbacks. The National Institutes of Health slowed spending significantly amid layoffs and policy changes this year, but has since ramped up spending after some terminations were reversed in court.
A coalition of New York medical schools and prominent research institutions is pushing Governor Kathy Hochul to commit billions of state dollars to a new biomedical research fund, citing the need to sustain existing research and jobs threatened by federal funding cuts under the Trump administration.
The proposed Empire Biomedical Research Institute would not only support ongoing research but also fuel New York's life sciences sector in the long term. According to supporters, including Jonathan Teyan, president and CEO of the Associated Medical Schools of New York, the new fund is essential for economic development and healthcare in New York state.
Federal funding for biomedical research has had a significant impact on the state, with over 30,000 jobs generated and $8 billion in economic activity last year. However, more than 1,000 research grants in New York have been impacted by federal funding cuts or freezes, leaving hundreds still affected.
The Associated Medical Schools of New York proposes starting the new state fund at $500 million and expanding it to $6 billion over the next decade. However, the proposal faces stiff competition for state funding going into the fiscal year 2027 budget session, with other high-priority initiatives on the table.
Ana Champeny, vice president for research at the Citizens Budget Commission, notes that lawmakers will need to determine priorities and allocate funds accordingly. "The legislators and the governor will need to figure out what are the priorities," she said.
Institutions such as Mount Sinai Health System, Columbia University, and the CUNY School of Medicine have made their case for prioritizing biomedical research in a letter to Governor Hochul, warning that without such a fund, they risk losing ground to other states and countries expanding their commitments to biomedical research.
New York state is already investing heavily in life sciences and innovation, including a $150 million investment in a cell and gene therapy innovation hub on Long Island. However, supporters argue that the state must also commit to supporting research at academic institutions to fuel the pipeline to commercial sector success.
The proposal comes as federal science funding remains in flux, with researchers saying research is still hobbled despite some reversals of cutbacks. The National Institutes of Health slowed spending significantly amid layoffs and policy changes this year, but has since ramped up spending after some terminations were reversed in court.